JF
VNDA icon

Jump Financial’s Vanda Pharmaceuticals VNDA Stock Holding History

Jump Financial’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.08M Buy
339,907
+141,040
+71% +$921K 0.02% 878
2026
Q1 		$1.37M Sell
198,867
-274,933
-58% -$2.12M 0.02% 801
2025
Q4 		$4.18M Buy
473,800
+335,800
+243% +$1.85M 0.05% 411
2025
Q3 		$689K Buy
+138,000
New +$639K 0.01% 1170
2025
Q1 		– Sell
-102,481
Closed -$491K – 2056
2024
Q4 		$491K Buy
102,481
+25,268
+33% +$121K 0.01% 1086
2024
Q3 		$362K Sell
77,213
-53,250
-41% -$285K 0.01% 1227
2024
Q2 		$737K Buy
+130,463
New +$674K 0.01% 953
2024
Q1 		– Sell
-64,400
Closed -$272K – 2336
2023
Q4 		$272K Sell
64,400
-8,952
-12% -$36.1K 0.01% 1392
2023
Q3 		$317K Sell
73,352
-20,932
-22% -$116K 0.01% 1272
2023
Q2 		$621K Buy
94,284
+45,184
+92% +$290K 0.02% 924
2023
Q1 		$333K Sell
49,100
-1,663
-3% -$11.7K 0.01% 1068
2022
Q4 		$375K Sell
50,763
-237
-0.5% -$2.31K 0.02% 905
2022
Q3 		$504K Sell
51,000
-3,100
-6% -$32.7K 0.02% 901
2022
Q2 		$590K Buy
+54,100
New +$561K 0.03% 777
2022
Q1 		– Sell
-50,387
Closed -$791K – 1940
2021
Q4 		$791K Buy
+50,387
New +$878K 0.05% 474
2021
Q2 		– Sell
-25,342
Closed -$381K – 1407
2021
Q1 		$381K Buy
+25,342
New +$410K 0.04% 510

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jump Financial's VNDA Position: Q2 2026 in Review

Jump Financial increased its Vanda Pharmaceuticals (VNDA) stake by 71% in Q2 2026, buying an estimated $921K and bringing the position to 339,907 shares worth $2.08M. The position accounts for 0.02% of the portfolio, ranked #878.

Jump Financial first reported a position in VNDA in Q1 2021 and has held it in 16 quarters since. The position peaked at $4.18M in Q4 2025. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Jump Financial held 339,907 shares of Vanda Pharmaceuticals worth $2.08M as of Q2 2026.
  • Jump Financial bought 141,040 Vanda Pharmaceuticals shares in Q2 2026, an estimated $921K.
  • Vanda Pharmaceuticals made up 0.02% of Jump Financial's portfolio in Q2 2026, its #878 holding.
  • Jump Financial first reported a position in Vanda Pharmaceuticals in Q1 2021 and has held it in 16 quarters since.
  • Jump Financial's Vanda Pharmaceuticals position peaked at $4.18M in Q4 2025.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.